Dr Karim F. Damji
Advancing Vision, Building Systems, and Expanding Access to Eye Care Worldwide
For Professor Karim Damji, restoring sight has never been only about treating disease; it has been about enabling people and building systems to ensure that patients can access high-quality eye care no matter where they live. Over more than three decades, his work has reshaped how glaucoma is diagnosed, treated, taught, and delivered, particularly for populations that have traditionally been left behind.
A globally respected clinician-scientist and educator, Dr Damji has spent his career at the intersection of patient care, innovation, and academic leadership. His research has helped redefine standards of glaucoma management worldwide, from demonstrating the effectiveness of selective laser trabeculoplasty to advancing minimally invasive glaucoma surgery that lowers eye pressure while preserving quality of life. Yet the true reach of his work extends beyond the operating room. By pioneering technology-enabled models of care, now known as teleglaucoma, he has helped bring specialist expertise to underserved communities, proving that geography need not be a barrier to sight-saving treatment.
That commitment to access and equity has guided Dr Damji's leadership across institutions and continents. As Chair of the Association of Canadian University Professors of Ophthalmology (ACUPO) and now as Dean of the Aga Khan University Medical College, Pakistan, he has consistently focused on strengthening academic capacity and developing future leaders in medicine. His vision is grounded in the belief that excellence in health care depends on well-trained professionals and leaders who are compassionate, technically skilled, ethically grounded, and responsive to local realities. At AKU, this philosophy has translated into an emphasis on competency-based education, blended learning, and the thoughtful integration of digital tools into medical care and training.
Professor Damji's influence is also visible in the global communities he has helped build. Through decades of teaching and mentorship, he has shaped generations of ophthalmologists and clinician-investigators, earning him global awards including the University of British Columbia Alumni Global Citizenship Award and the American Glaucoma Society humanitarian award. His leadership in professional societies, including serving as President of the Canadian Glaucoma Society, reflects a career devoted not only to advancing science but also to strengthening the discipline itself.
His scholarly contributions, more than 190 peer-reviewed publications and senior editorial leadership of the Shields Textbook of Glaucoma, have informed clinical practice around the world. But numbers alone do not explain why his work continues to matter. They represent safer surgeries, earlier diagnoses, and countless patients whose vision has been protected because research was translated into real-world care.
In recognition of this sustained global impact, Professor Damji was named among Stanford University's Top 2% most cited scientists in 2024, joining a small group of researchers whose work has demonstrably shaped their fields. For him, however, recognition is secondary to purpose. Whether developing new surgical approaches, expanding access to care in sub-Saharan Africa, or guiding the next chapter of medical education at AKU, his focus remains constant: improving quality of life through science, innovation and service.
